Cargando…
C-Reactive Protein and White Blood Cell Count in Cardiogenic Shock
This study examines the prognostic impact of C-reactive protein (CRP) and white blood cell (WBC) counts in patients with cardiogenic shock (CS). Data regarding the prognostic impact of inflammatory biomarkers in CS are scarce. All consecutive patients with CS from 2019 to 2021 admitted to a cardiac...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917886/ https://www.ncbi.nlm.nih.gov/pubmed/36769613 http://dx.doi.org/10.3390/jcm12030965 |
_version_ | 1784886476086968320 |
---|---|
author | Dudda, Jonas Schupp, Tobias Rusnak, Jonas Weidner, Kathrin Abumayyaleh, Mohammad Ruka, Marinela Egner-Walter, Sascha Forner, Jan Müller, Julian Bertsch, Thomas Kittel, Maximilian Akin, Ibrahim Behnes, Michael |
author_facet | Dudda, Jonas Schupp, Tobias Rusnak, Jonas Weidner, Kathrin Abumayyaleh, Mohammad Ruka, Marinela Egner-Walter, Sascha Forner, Jan Müller, Julian Bertsch, Thomas Kittel, Maximilian Akin, Ibrahim Behnes, Michael |
author_sort | Dudda, Jonas |
collection | PubMed |
description | This study examines the prognostic impact of C-reactive protein (CRP) and white blood cell (WBC) counts in patients with cardiogenic shock (CS). Data regarding the prognostic impact of inflammatory biomarkers in CS are scarce. All consecutive patients with CS from 2019 to 2021 admitted to a cardiac intensive care unit (ICU) were included at one institution. Laboratory measurements were retrieved from the day of admission (i.e., day 1), as well as days 2, 3, 4, and 8. The primary endpoint was 30-day all-cause mortality. Statistical analyses included univariate t-tests, Spearman’s correlations, C-statistics, Kaplan–Meier, and Cox regression analyses. From a total of 240 consecutive patients admitted with CS, 55% died within 30 days. CRP levels on days 3 to 8 were associated with reliable discrimination for 30-day all-cause mortality (area under the curve (AUC): 0.623–0.754), whereas CRP on day 1 was not (AUC = 0.514). In line, CRP > 100 mg/L on day 3 (56% vs. 37%; log-rank p = 0.023; HR = 1.702; 95% CI 1.060–2.735; p = 0.028) and especially a CRP increase of at least 200% from days 1 to day 3 (51% vs. 35%; log-rank p = 0.040; HR = 1.720; 95% CI 1.006–2.943; p = 0.048) were associated with an increased risk of all-cause mortality. Furthermore, WBC on day 1 discriminated 30-day all-cause mortality (AUC = 0.605; p = 0.005) with an increased risk of all-cause mortality in patients admitted with WBC > 10 × 10(6)/mL (59% vs. 40%; log-rank p = 0.036; HR = 1.643; 95% CI 1.010–2.671; p = 0.045). In conclusion, WBC count on admission as well as CRP levels during the course of ICU treatment were associated with 30-day all-cause mortality. Specifically, an increase of CRP levels by at least 200% from day 1 to day 3 during the course of ICU treatment was associated with an increased risk of 30-day all-cause mortality. The present study is one of the first to describe the prognostic value of inflammatory biomarkers in consecutive all-comer CS patients treated at a cardiac ICU. |
format | Online Article Text |
id | pubmed-9917886 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99178862023-02-11 C-Reactive Protein and White Blood Cell Count in Cardiogenic Shock Dudda, Jonas Schupp, Tobias Rusnak, Jonas Weidner, Kathrin Abumayyaleh, Mohammad Ruka, Marinela Egner-Walter, Sascha Forner, Jan Müller, Julian Bertsch, Thomas Kittel, Maximilian Akin, Ibrahim Behnes, Michael J Clin Med Article This study examines the prognostic impact of C-reactive protein (CRP) and white blood cell (WBC) counts in patients with cardiogenic shock (CS). Data regarding the prognostic impact of inflammatory biomarkers in CS are scarce. All consecutive patients with CS from 2019 to 2021 admitted to a cardiac intensive care unit (ICU) were included at one institution. Laboratory measurements were retrieved from the day of admission (i.e., day 1), as well as days 2, 3, 4, and 8. The primary endpoint was 30-day all-cause mortality. Statistical analyses included univariate t-tests, Spearman’s correlations, C-statistics, Kaplan–Meier, and Cox regression analyses. From a total of 240 consecutive patients admitted with CS, 55% died within 30 days. CRP levels on days 3 to 8 were associated with reliable discrimination for 30-day all-cause mortality (area under the curve (AUC): 0.623–0.754), whereas CRP on day 1 was not (AUC = 0.514). In line, CRP > 100 mg/L on day 3 (56% vs. 37%; log-rank p = 0.023; HR = 1.702; 95% CI 1.060–2.735; p = 0.028) and especially a CRP increase of at least 200% from days 1 to day 3 (51% vs. 35%; log-rank p = 0.040; HR = 1.720; 95% CI 1.006–2.943; p = 0.048) were associated with an increased risk of all-cause mortality. Furthermore, WBC on day 1 discriminated 30-day all-cause mortality (AUC = 0.605; p = 0.005) with an increased risk of all-cause mortality in patients admitted with WBC > 10 × 10(6)/mL (59% vs. 40%; log-rank p = 0.036; HR = 1.643; 95% CI 1.010–2.671; p = 0.045). In conclusion, WBC count on admission as well as CRP levels during the course of ICU treatment were associated with 30-day all-cause mortality. Specifically, an increase of CRP levels by at least 200% from day 1 to day 3 during the course of ICU treatment was associated with an increased risk of 30-day all-cause mortality. The present study is one of the first to describe the prognostic value of inflammatory biomarkers in consecutive all-comer CS patients treated at a cardiac ICU. MDPI 2023-01-27 /pmc/articles/PMC9917886/ /pubmed/36769613 http://dx.doi.org/10.3390/jcm12030965 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dudda, Jonas Schupp, Tobias Rusnak, Jonas Weidner, Kathrin Abumayyaleh, Mohammad Ruka, Marinela Egner-Walter, Sascha Forner, Jan Müller, Julian Bertsch, Thomas Kittel, Maximilian Akin, Ibrahim Behnes, Michael C-Reactive Protein and White Blood Cell Count in Cardiogenic Shock |
title | C-Reactive Protein and White Blood Cell Count in Cardiogenic Shock |
title_full | C-Reactive Protein and White Blood Cell Count in Cardiogenic Shock |
title_fullStr | C-Reactive Protein and White Blood Cell Count in Cardiogenic Shock |
title_full_unstemmed | C-Reactive Protein and White Blood Cell Count in Cardiogenic Shock |
title_short | C-Reactive Protein and White Blood Cell Count in Cardiogenic Shock |
title_sort | c-reactive protein and white blood cell count in cardiogenic shock |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917886/ https://www.ncbi.nlm.nih.gov/pubmed/36769613 http://dx.doi.org/10.3390/jcm12030965 |
work_keys_str_mv | AT duddajonas creactiveproteinandwhitebloodcellcountincardiogenicshock AT schupptobias creactiveproteinandwhitebloodcellcountincardiogenicshock AT rusnakjonas creactiveproteinandwhitebloodcellcountincardiogenicshock AT weidnerkathrin creactiveproteinandwhitebloodcellcountincardiogenicshock AT abumayyalehmohammad creactiveproteinandwhitebloodcellcountincardiogenicshock AT rukamarinela creactiveproteinandwhitebloodcellcountincardiogenicshock AT egnerwaltersascha creactiveproteinandwhitebloodcellcountincardiogenicshock AT fornerjan creactiveproteinandwhitebloodcellcountincardiogenicshock AT mullerjulian creactiveproteinandwhitebloodcellcountincardiogenicshock AT bertschthomas creactiveproteinandwhitebloodcellcountincardiogenicshock AT kittelmaximilian creactiveproteinandwhitebloodcellcountincardiogenicshock AT akinibrahim creactiveproteinandwhitebloodcellcountincardiogenicshock AT behnesmichael creactiveproteinandwhitebloodcellcountincardiogenicshock |